Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 07/30 10:00:47 am
124.45 USD   -0.93%
07/29 VERTEX PHARMACE : reports 2Q loss
07/29 VERTEX PHARMACE : Reports Second Quarter 2015 Financial Results
07/29DJVERTEX PHARMACE : Revenue Rises 20%
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/24/2015 07/27/2015 07/28/2015 07/29/2015 07/30/2015 Date
125.5(c) 123.23(c) 128.3(c) 125.62(c) 124.45 Last
1 362 793 2 042 296 1 944 884 1 785 295 334 804 Volume
-4.09% -1.81% +4.11% -2.09% -0.93% Change
More quotes
Financials ($)
Sales 2015 953 M
EBIT 2015 -366 M
Net income 2015 -542 M
Finance 2015 479 M
Yield 2015 -
Sales 2016 2 668 M
EBIT 2016 1 091 M
Net income 2016 842 M
Finance 2016 1 556 M
Yield 2016 -
PER 2015 -
PER 2016 38,20
EV / Sales 2015 31,6x
EV / Sales 2016 10,9x
Capitalization 30 620 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
Sector
Pharmaceuticals
Calendar
07/29Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
07/29 VERTEX PHARMACEUTICALS : reports 2Q loss
07/29 VERTEX PHARMACEUTICALS : Reports Second Quarter 2015 Financial Results
07/29DJVERTEX PHARMACEUTICALS : Revenue Rises 20%
07/22 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2015 Financial Results on Ju..
07/15 VERTEX PHARMACEUTICALS : FDA Approves ORKAMBI™ lumacaftor/ivacaftor - the ..
07/15 VERTEX PHARMACEUTICALS : Study Data from Vertex Pharmaceuticals Inc. Provide New..
07/15 VERTEX PHARMACEUTICALS : FDA Greenlights Vertex' ORKAMBI Cystic Fibrosis Medicin..
07/14 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2015 Financial Results on Ju..
More news
Sector news : Biopharmaceuticals
05:43aDJDr. Reddy's April-June Net Profit Rises 14%
05:36a NOVARTIS : Mereo BioPharma Acquires Clinical Assets from Novartis
05:17a Sanofi's diabetes sales slow, Genzyme's jump
More sector news : Biopharmaceuticals
News from SeekingAlpha
12:11a Vertex Pharmaceuticals (VRTX) Jeffrey M. Leiden on Q2 2015 Results - Earnings..
07/29 Vertex Q2 loss widens; KALYDECO revenue up 37%; shares up 2% AH
07/29 Vertex Pharmaceuticals beats by $0.04, beats on revenue
07/29 Vertex Pharma reports after the close
07/24 PREMARKET BIOTECH DIGEST : The PCSK9 Race, AbbVie Earnings, Inotek Jumps 200%


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions